Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.16 USD | -9.54% | +0.16% | +43.93% |
May. 09 | Transcript : Lantern Pharma Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 06 | Lantern Pharma, Oregon Therapeutics Partner to Develop AI-Driven Cancer Drug Collaboration | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- LTRN Stock
- Revisions Lantern Pharma Inc.